GPHL on March 12th appointed Randy Schekman, the 2013 Nobel Laureate in Physiology or Medicine, as the chief scientist of both the group and its subsidiary Guangzhou General Pharmaceutical Research In
GPHL, the largest pharmaceutical company in China, established Guangzhou Pharmaceutical Group (Macau) International Development Co. and held a plaque unveiling ceremony on January 3rd.
First, it will strengthen collaboration between Guangdong and Macao, and help develop the economic diversification of Macao.
Malaysia’s trade promotion agency, MATRADE, Consulate General of Malaysia in Guangzhou, are organizing a Market Immersion to Guangzhou from 18th to 21st.
Traditional Chinese Medicine (TCM) has been further incorporated into medical systems of Belt and Road countries due to China's increased medical exchanges and cooperation in the region.
The TCM industrial park now boasts 159 registered companies in areas including TCM, health products, medical equipment and services, and biomedicine, 39 of which are from Macao.
The first ever traditional Chinese medicine (TCM) for bronchitis, the Yinhuang Qingfei Capsule, have passed a one-year trial against its competitor antibiotic medicine...
Guest lecturers from east China's Jiangxi province held a presentation on traditional Chinese medicine (TCM) here on Monday at an event meant to establish bilateral cooperation in this field.
GPHL’s chief scientist Randy Schekman attends the 6th Traditional Chinese Medicine Science Conferenc
Nobel laureates, academics, TCM masters, well-known TCM practitioners, experts and scholars specialized in life sciences and TCM attended the conference.
At the GPHL Strategic Conference 2019, GPHL subsidiary Guangzhou Wanglaoji Pharmaceutical Co., Ltd. announced a strategic partnership with Dufen International.
On August 15th, GPHL signed an agreement with Fortune and became the presenting partner of 2019’s Fortune Global Tech Forum.